Search Results for Clinical trials terminology
![](/resources/img/sponsored_links.png)
![](/resources/img/sponsored_links.png)
Keyword Popularity ![](/resources/img/clear.gif)
60 out of 1000
Competition Index ![](/resources/img/clear.gif)
10 out of 1000
Keyword Advertise Index ![](/resources/img/clear.gif)
10 out of 1000
Position | Website | Change | Thumbnail |
---|---|---|---|
1 |
|
0 | ![]() |
2 |
CenterWatch provides a variety of clinical research products and services: including trial listings and results, drug approvals, study grants, news and analysis, career and training opportunities for patients and professionals.
|
0 | ![]() |
3 |
|
0 | ![]() |
4 |
|
0 | ![]() |
5 |
Home page of the Clinical Data Interchange Standards Consortium. What
|
0 | ![]() |
6 |
Official website of the National Institutes of Health (NIH). NIH is one of the world
|
0 | ![]() |
7 |
|
0 | ![]() |
8 |
|
0 | ![]() |
9 |
|
0 | ![]() |
10 |
The Clinical & Translational Research Institute is part of a national consortium that aims to improve human health by transforming the research and training environment to enhance the efficiency and quality of clinical and translational research.
|
0 | ![]() |
11 |
|
0 | ![]() |
12 |
The Sue Stiles Program in Integrative Oncology was established at UCLA
|
0 | ![]() |
13 |
Roche is systematically pursuing personalised medicine – it is an approach that is capable of increasing the safety, efficacy and cost-efficiency of treatment.
|
0 | ![]() |
14 |
Learn more about Sanofi Oncology, our products, our ongoing research and pipeline agents.
|
0 | ![]() |
15 |
Accurate, up-to-date, comprehensive cancer information from the U.S. government
|
0 | ![]() |
Related keywords by Clinical trials terminology
I have no idea. Please, refresh tomorrow ;)
Most popular sites by Clinical trials terminology
Site | Traffic ![]() |
Engagement ![]() |
---|---|---|
clinicaltrials.gov | 41.2% | 0x |
wwwlb.aub.edu.lb/~webmedic | 9.4% | 0x |
findpharma.com | 8.2% | 0x |
novartisclinicaltrials.com | 7.6% | 0x |
lexjansen.com | 7.2% | 0x |
Other | 26.4% | 0x |